ELM-2: QoL and ORR outcomes of odronextamab treatment for R/R FL VJHemOnc – Video Journal of Hematology & HemOnc 0:43 11 months ago 54 Далее Скачать
Dr. Luminari Remarks on EU Approval of Odronextamab for DLBCL, Follicular Lymphoma Blood Cancers Today 6:46 2 months ago 159 Далее Скачать
Promising Results for Odronextamab in Post CAR T Patients with DLBCL | Jennifer Crombie, MD | #ASH24 HealthTree Foundation for Blood Cancers 2:39 13 days ago 12 Далее Скачать
Lymphoma: odronextamab (REGN197) VJHemOnc – Video Journal of Hematology & HemOnc 3:27 5 years ago 51 Далее Скачать
Safety & Efficacy of Odronextamab for DLBCL After CAR-T Failure | Matthew Matasar, MD | #ASH24 HealthTree Foundation for Blood Cancers 2:15 9 days ago 7 Далее Скачать
Interim analysis of the ELM-2 study: odronextamab in patients with R/R follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:43 11 months ago 164 Далее Скачать
Odronextamab in CAR-T relapsed diffuse large B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:06 9 months ago 451 Далее Скачать
ELM-2: promising safety and efficacy of odronextamab in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:02 10 months ago 134 Далее Скачать
Efficacy of odronextamab in R/R DLBCL & determining the optimal sequencing of immune therapies VJHemOnc – Video Journal of Hematology & HemOnc 1:51 1 year ago 227 Далее Скачать
OLYMPIA-5: odronextamab + lenalidomide for R/R indolent lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 196 Далее Скачать
Updates in bispecifics for DLBCL from ASH: glofitamab, odronextamab, epcoritamab & mosunetuzumab VJHemOnc – Video Journal of Hematology & HemOnc 4:31 1 year ago 1 085 Далее Скачать
Odronextamab in R/R B-cell non-Hodgkin lymphomas VJHemOnc – Video Journal of Hematology & HemOnc 6:26 4 years ago 681 Далее Скачать
The pharmacometrics of odronextamab in R/R FL & DLBCL based on the ELM-1 & 2 studies VJHemOnc – Video Journal of Hematology & HemOnc 1:30 6 months ago 98 Далее Скачать
Primary analysis of the ELM-2: odronextamab in heavily pretreated R/R FL VJHemOnc – Video Journal of Hematology & HemOnc 5:04 5 months ago 166 Далее Скачать
What do the ELM-2 results tell us about the efficacy of odronextamab for R/R DLBCL? Lymphoma Hub 1:51 1 year ago 124 Далее Скачать
CD20-targeted CAR T-Cell therapy for patients with indolent B-cell NHL VJHemOnc – Video Journal of Hematology & HemOnc 1:33 10 months ago 188 Далее Скачать
Checkpoint inhibitor/bispecific antibody combo: REGN2810 and REGN1979 in B-lymphoid malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:13 6 years ago 188 Далее Скачать
ELM-2 trial: using ctDNA and MRD to measure odronextamab outcomes in DLBCL and FL VJHemOnc – Video Journal of Hematology & HemOnc 2:01 10 months ago 151 Далее Скачать
Results from the Phase II ELM-2 trial: odronextamab for R/R follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:23 1 year ago 302 Далее Скачать
